Microbial Genomics as a Catalyst for Targeted Antivirulence Therapeutics

Virulence arresting drugs (VAD) are an expanding class of antimicrobial treatment that act to “disarm” rather than kill bacteria. Despite an increasing number of VAD being registered for clinical use, uptake is hampered by the lack of methods that can identify patients who are most likely to benefit...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Front Med (Lausanne)
Autores principales: Sintchenko, Vitali, Timms, Verlaine, Sim, Eby, Rockett, Rebecca, Bachmann, Nathan, O'Sullivan, Matthew, Marais, Ben
Formato: Artigo
Lenguaje:Inglês
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8076527/
https://ncbi.nlm.nih.gov/pubmed/33928102
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmed.2021.641260
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares